| dc.contributor.author | Phimister, EG | |
| dc.contributor.author | Hattersley, Andrew T. | |
| dc.contributor.author | Thorens, B | |
| dc.date.accessioned | 2015-09-16T14:37:01Z | |
| dc.date.issued | 2015-09-03 | |
| dc.description.abstract | No abstract | en_GB |
| dc.identifier.citation | Vol. 373, pp. 974 - 976 | en_GB |
| dc.identifier.doi | 10.1056/NEJMcibr1506573 | |
| dc.identifier.uri | http://hdl.handle.net/10871/18258 | |
| dc.language.iso | en | en_GB |
| dc.publisher | Massachusetts Medical Society | en_GB |
| dc.relation.url | http://www.nejm.org/doi/full/10.1056/NEJMcibr1506573 | en_GB |
| dc.rights.embargoreason | Publisher's policy | en_GB |
| dc.title | Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion | en_GB |
| dc.type | Article | en_GB |
| dc.identifier.issn | 0028-4793 | |
| dc.description | From New England Journal of Medicine, Hattersley, A. T., & Thorens, B. (2015). Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion. 373(10), 974-976. Copyright © 2015 Massachusetts Medical Society. Reprinted with permission. | en_GB |
| dc.identifier.journal | New England Journal of Medicine | en_GB |
